Immunomodulation of EA-230 Following On-pump Coronary Artery Bypass Grafting (CABG)

Clinical trial NCT03145220 · UNKNOWN

Trial details

NCT number: NCT03145220
Sponsor: Radboud University Medical Center
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Systemic Inflammatory Response Syndrome Coronary Artery Bypass Grafting

Start date: 2016-06-01
Primary completion: 2018-10-01
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.